CSL Limited CSLLY Stock
CSL Limited Price Chart
CSL Limited CSLLY Financial and Trading Overview
| CSL Limited stock price | 91.4 USD |
| Previous Close | 97.5 USD |
| Open | 95.74 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 95.52 - 96.55 USD |
| 52 Week Range | 83.3 - 110.25 USD |
| Volume | 40.14K USD |
| Avg. Volume | 31.09K USD |
| Market Cap | 93.13B USD |
| Beta (5Y Monthly) | 0.217241 |
| PE Ratio (TTM) | 44.69166 |
| EPS (TTM) | 2.54 USD |
| Forward Dividend & Yield | 1.12 (1.14%) |
| Ex-Dividend Date | March 8, 2023 |
| 1y Target Est | N/A |
CSLLY Valuation Measures
| Enterprise Value | 106.85B USD |
| Trailing P/E | 44.69166 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.956974 |
| Price/Book (mrq) | 5.9390917 |
| Enterprise Value/Revenue | 9.129 |
| Enterprise Value/EBITDA | 31.007 |
Trading Information
CSL Limited Stock Price History
| Beta (5Y Monthly) | 0.217241 |
| 52-Week Change | 9.76% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 110.25 USD |
| 52 Week Low | 83.3 USD |
| 50-Day Moving Average | 101.12 USD |
| 200-Day Moving Average | 98.13 USD |
CSLLY Share Statistics
| Avg. Volume (3 month) | 31.09K USD |
| Avg. Daily Volume (10-Days) | 31.43K USD |
| Shares Outstanding | 964.74M |
| Float | 962.25M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.073% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 2.25 |
| Trailing Annual Dividend Yield | 2.30% |
| 5 Year Average Dividend Yield | 108.00% |
| Payout Ratio | 0.5139 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 18.09% |
| Operating Margin (ttm) | 25.38% |
| Gross Margin | 52.52% |
| EBITDA Margin | 29.44% |
Management Effectiveness
| Return on Assets (ttm) | 6.30% |
| Return on Equity (ttm) | 13.37% |
Income Statement
| Revenue (ttm) | 11.7B USD |
| Revenue Per Share (ttm) | 12.16 USD |
| Quarterly Revenue Growth (yoy) | 18.89% |
| Gross Profit (ttm) | 5.73B USD |
| EBITDA | 3.45B USD |
| Net Income Avi to Common (ttm) | 2.12B USD |
| Diluted EPS (ttm) | 2.16 |
| Quarterly Earnings Growth (yoy) | -7.79% |
Balance Sheet
| Total Cash (mrq) | 1.51B USD |
| Total Cash Per Share (mrq) | 1.56 USD |
| Total Debt (mrq) | 12.12B USD |
| Total Debt/Equity (mrq) | 67.77 USD |
| Current Ratio (mrq) | 2.218 |
| Book Value Per Share (mrq) | 16.254 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.18B USD |
| Levered Free Cash Flow (ttm) | -113812496 USD |
Profile of CSL Limited
| Country | United States |
| State | VIC |
| City | Parkville |
| Address | 45 Poplar Road |
| ZIP | 3052 |
| Phone | 61 3 9389 1911 |
| Website | https://www.csl.com.au |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 30000 |
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Q&A For CSL Limited Stock
What is a current CSLLY stock price?
CSL Limited CSLLY stock price today per share is 91.4 USD.
How to purchase CSL Limited stock?
You can buy CSLLY shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CSL Limited?
The stock symbol or ticker of CSL Limited is CSLLY.
Which industry does the CSL Limited company belong to?
The CSL Limited industry is Biotechnology.
How many shares does CSL Limited have in circulation?
The max supply of CSL Limited shares is 974.06M.
What is CSL Limited Price to Earnings Ratio (PE Ratio)?
CSL Limited PE Ratio is 36.02756000 now.
What was CSL Limited earnings per share over the trailing 12 months (TTM)?
CSL Limited EPS is 2.54 USD over the trailing 12 months.
Which sector does the CSL Limited company belong to?
The CSL Limited sector is Healthcare.